Overview
- Editors:
-
-
Maurie Markman
-
Leonard B. Saltz
-
Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York
Access this book
Other ways to access
Table of contents (15 chapters)
-
-
-
- Yu-Ning Wong, Wen-Chi Chang, Margie Clapper, Paul F. Engstrom
Pages 33-49
-
-
- M.Wasif Saif, Richard Kim, Edward Chu
Pages 69-84
-
- John M. Strother, Charles D. Blanke
Pages 85-98
-
- Nabeel Shalan, Paulo M. Hoff
Pages 99-118
-
- Anthony B. El-Khoueiry, Heinz-Josef Lenz
Pages 119-130
-
- Bert H. O’Neil, Hanna Kelly, Michael A. Morse, Richard M. Goldberg
Pages 131-154
-
- Yu Jo Chua, David Cunningham
Pages 155-189
-
- Axel Grothey, Steven A. Alberts
Pages 191-203
-
-
- Sean D. Curran, Laurence H. Schwartz
Pages 219-229
-
- Ellen Hollywood, Deborah Semple
Pages 231-243
-
-
- Chris Takimoto, Russell Kruzelock
Pages 263-279
-
Back Matter
Pages 281-292
About this book
Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made.
Editors and Affiliations
-
Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York
Leonard B. Saltz